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Dear Editors, 
 
I thank Mr Barrett, Mr Blickman and Dr Lines for taking the time to share their comments on my paper. 
 
As to the methodological issues raised: 
Mr Barrett and Blickman are clearly mistaking interpretive disagreements for methodological issues. 
My piece is an impressionistic account aimed at contemporary historiography. If Mr Barrett’s claim in 
particular is to stand I'd be interested to hear how the other pieces in this special issue differ in 
methodology from mine or what academic background he claims enabling him to offer such a 
statement. The only point raised is that I didn't conduct 'interviews', which is incorrect as I reference 
private discussions to anonymise my sources. Further, I would highlight that I have published 
elsewhere on the poor historicising in this field which I think applies to these critics’ works in a number 
of cases.
i
 
 
Mr Barrett is incorrect to assert that I was not present at many of these discussions nor did I have 
access to strategy documents. I was present at (too) many civil society forums, closed door 
gatherings, strategic discussions and conferences during the process. As anyone close to the process 
would attest, strategic documents were circulated widely among civil society groupings and I 
referenced a number of publicly available documents in my paper.   
 
The key problem of those who ‘bear the brunt’ of my attack is that, under this author’s opinion, they do 
not recognise the limits imposed by their own interpretive biases. My basic point stands, that of a 
fundamental contradiction between the ideas of those wanting to expand states’ rights in more liberal 
directions through more complex interpretations of international treaty obligations, and those seeking 
to highlight the ‘full range of options’ so as to demonstrate the latter as clear, certain and closed and 
thereby limited to ‘prohibition’ and ultimately driving towards a ‘collision’ with the international system. 
The seeming inability of many reformists to recognise a potential trade-off between those two 
approaches is, as my paper seeks to suggest, at the heart of their strategic contradictions and thereby 
failings. 
 
As for Mr Blickman’s interesting counter: 
 
He is of course wrong that I was the only proponent of the 'progressive school'. The UK All Party 
Parliamentary Group on Drug Policy Reform accepted the premise of a reinterpretive and flexibilities-
based approach and argued for this in their Guidance.
ii
 Governments and UN officials were quietly 
and often publicly supportive of this initiative - for example hosting events at CND and in the lead-up 
to UNGASS in NYC. Meanwhile, INCB member Francisco Thoumi wrote with a similar approach, 
highlighting legal inconsistencies within the Conventions rendering their interpretive scope far broader 
than previously explored.
iii
 Further, the letter of the Uruguayan Foreign Ministry to INCB is archetypal 
of the views which I term 'the progressive School'.
iv
 This is not to mention the US and Canadian 
approaches to interpretive reform. Lastly, ‘flexibilities’ were explicitly written into the UNGASS 
Outcome Document as a means to enable further reforms.
v
 The much advocated ‘expert commission’ 
did not come to pass and many of the processes he mentioned were omitted as they seem destined 
for historical obscurity. 
 
As to Mr Barrett and Mr Blickman’s post-hoc claims of strategic logic among the groups in question I, 
with a great deal of respect to those concerned, colour myself deeply sceptical. 
 
Meanwhile, I agree, as Dr Lines convincingly demonstrates, HRI maintained a strong advocacy 
strategy throughout the process aimed at achieving tangible results in terms of harm reduction. For 
example, I would argue their 10by20 campaign represented one of the most tangible advocacy 
campaigns around the UNGASS process.
vi
 Indeed my conclusion on the normative shifts evident at 
UNGASS specifically relates to the language around harm reduction interventions and public health 
approaches. My article did not, or did not seek, to portray otherwise. I referenced Dr Lines and Mr 
Barrett's work as an early example of a division in narrative whereby some civil society groups 
described UNGASS in terms of unexpected failure, while others began to unpick the substantial 
progress made. For example, to quote one reformer soon after UNGASS, 'the UN drug control system 
was faced with a choice: evolve or die. They have chosen the latter. It now falls to reform-minded 
states and civil society to build something better from the ashes of this UNGASS'.
vii
 It is against this 
narrative, which dominated some reformist discourses, that I sought to juxtapose Dr Lines and Mr 
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Barrett's more measured analysis.
viii
 If I did not make the distinction clear enough in my article it was 
out of a desire not to overly personalise. Although a generalist narrative of UNGASS being a partial 
'success' has recently solidified, even since I wrote the article in question, the quotation I give above 
should re-highlight that this was absolutely not the broad perception at the time. 
 
My article was an attempt to challenge a perceived lack of self-reflection in pre and post-UNGASS 
strategic analyses among key civil society actors. I take these responses as having fuelled some 
introspection, even as interpretive differences remain wide.  
 
Sincerely, 
 
Dr John Collins 
Executive Director, LSE IDEAS International Drug Policy Project. 
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